Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Voriconazole-induced periostitis.

Literature DB >> 26032311

Voriconazole-induced periostitis.

Tetiana Glushko¹, Inés Colmegna².

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2015 PMID： 26032311 PMCID： PMC4592302 DOI： 10.1503/cmaj.141025

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

5 in total

1. Fluoride and bone--quantity versus quality.

Authors: R Lindsay
Journal: N Engl J Med Date: 1990-03-22 Impact factor: 91.245

2. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.

Authors: Robert A Wermers; Kay Cooper; Raymund R Razonable; Paul J Deziel; Gary M Whitford; Walter K Kremers; Thomas P Moyer
Journal: Clin Infect Dis Date: 2011-01-16 Impact factor: 9.079

3. Periosteal reaction induced by prostaglandins.

Authors: J G Niethammer; K A Rule; V Lorch; M E Anderson
Journal: Am J Perinatol Date: 1992-07 Impact factor: 1.862

4. Periostitis secondary to interleukin-11 (Oprelvekin, Neumega). Treatment for thrombocytopenia in pediatric patients.

Authors: Edward Milman; Walter E Berdon; James H Garvin; Mitchell S Cairo; Olga Bessmertny; Carrie Ruzal-Shapiro
Journal: Pediatr Radiol Date: 2003-05-01

5. Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.

Authors: Bernhard Gerber; Roman Guggenberger; David Fasler; Gayathri Nair; Markus G Manz; Georg Stussi; Urs Schanz
Journal: Blood Date: 2012-08-02 Impact factor: 22.113

5 in total

3 in total

Voriconazole-induced periostitis.

1. Fluoride and bone--quantity versus quality.

2. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.

3. Periosteal reaction induced by prostaglandins.

4. Periostitis secondary to interleukin-11 (Oprelvekin, Neumega). Treatment for thrombocytopenia in pediatric patients.

5. Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.

1. Spectrum of voriconazole-associated periostitis in clinical characteristics, diagnosis and management.

Review 2. Voriconazole-induced periostitis: a new rheumatic disorder.

3. Voriconazole-Induced Periostitis & Enthesopathy in Solid Organ Transplant Patients: Case Reports.